9,303 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
UPS United Parcel Service, Inc. $119.09 $102.46B Downtrend
Article Searches
Edmunds rounds up best budget-friendly small cars http://www.startribune.com/business/497789701.html Oct 17, 2018 -
UPS to Grow Footprint Via UPS My Choice Across 112 Countries http://www.zacks.com/stock/news/328517/ups-to-grow-footprint-via-ups-my-choice-across-112-countries?cid=CS-ZC-FT-328517 Oct 17, 2018 - UPS aims at enhancing customer experience by expanding the UPS My Choice service in the near term to additional 96 countries.
AmerisourceBergen perks up on chance of WBA deal; shares up 4% https://seekingalpha.com/news/3397762-amerisourcebergen-perks-chance-wba-deal-shares-4-percent?source=feed_news_all Oct 16, 2018 -
IFF: Deutsche Bank ups to Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20181016133927 Oct 16, 2018 - Deutsche Bank issues rating change for IFF
Axsome Therapeutics adds new pipeline candidate for narcolepsy; shares up 3% https://seekingalpha.com/news/3397739-axsome-therapeutics-adds-new-pipeline-candidate-narcolepsy-shares-3-percent?source=feed_news_all Oct 16, 2018 - Axsome Therapeutics (AXSM +3.3%) is up on below-average volume following its announcement that it has added a new candidate to its pipeline, AXS-12, that it will develop for a sleep disorder called na
Five Prime starts dose exploration in early-stage study of FPA150 in solid tumors; shares up 4% https://seekingalpha.com/news/3397711-five-prime-starts-dose-exploration-early-stage-study-fpa150-solid-tumors-shares-4-percent?source=feed_news_all Oct 16, 2018 - Thinly traded small cap Five Prime Therapeutics (FPRX +3.8%) is up on below-average volume following its announcement that dosing is underway in the dose exploration cohort of its ongoing Phase 1 clin
CGNX: Needham ups to Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20181016072156 Oct 16, 2018 - Needham issues rating change for CGNX
TPR: Needham ups to Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20181016072001 Oct 16, 2018 - Needham issues rating change for TPR
ABUS: B. Riley FBR ups to Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20181016071441 Oct 16, 2018 - B. Riley FBR issues rating change for ABUS
ALRM: First Analysis Sec ups to Strong Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20181016065036 Oct 16, 2018 - First Analysis Sec issues rating change for ALRM

Pages: 1234567891011...931

<<<Page 6>